<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">medgen</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинская генетика</journal-title><trans-title-group xml:lang="en"><trans-title>Medical Genetics</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2073-7998</issn><publisher><publisher-name>Publishing House «Genius Media» LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.25557/2073-7998.2020.11.58-60</article-id><article-id custom-type="elpub" pub-id-type="custom">medgen-1797</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КРАТКИЕ СООБЩЕНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>BRIEF REPORT</subject></subj-group></article-categories><title-group><article-title>Влияние новых водорастворимых производных фуллерена C60, имеющих одинаковые заместители и одну замену CL→ME на экспрессию генов и активность транскрипционных факторов NRF2 и NFkB</article-title><trans-title-group xml:lang="en"><trans-title>The effect of new water-soluble derivatives of C60 fullerene having identical substituents and one substitution CL→ME on gene expression and the activity of transcription factors NRF2 and NFkB</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Савинова</surname><given-names>Е. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Savinova</surname><given-names>E. A.</given-names></name></name-alternatives><email xlink:type="simple">savinova.ekaterina96@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ершова</surname><given-names>Е. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Ershova</surname><given-names>E. S.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Родионов</surname><given-names>И. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Rodionov</surname><given-names>I. V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Вейко</surname><given-names>Н. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Veiko</surname><given-names>N. N.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Краевая</surname><given-names>О. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Kraevaya</surname><given-names>O. A.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Трошин</surname><given-names>П. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Troshin</surname><given-names>P. A.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Костюк</surname><given-names>С. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Kostyuk</surname><given-names>S. V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБНУ «Медико-генетический научный центр имени академика Н.П. Бочкова»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Research Centre for Medical Genetics</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Сколковский институт науки и технологий; Институт проблем химической физики РАН</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Skolkovo Institute of Science and Technology; Institute of Problems of Chemical Physics of the Russian Academy of Sciences</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>02</day><month>02</month><year>2021</year></pub-date><volume>19</volume><issue>11</issue><fpage>58</fpage><lpage>60</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Савинова Е.А., Ершова Е.С., Родионов И.В., Вейко Н.Н., Краевая О.А., Трошин П.А., Костюк С.В., 2021</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="ru">Савинова Е.А., Ершова Е.С., Родионов И.В., Вейко Н.Н., Краевая О.А., Трошин П.А., Костюк С.В.</copyright-holder><copyright-holder xml:lang="en">Savinova E.A., Ershova E.S., Rodionov I.V., Veiko N.N., Kraevaya O.A., Troshin P.A., Kostyuk S.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.medgen-journal.ru/jour/article/view/1797">https://www.medgen-journal.ru/jour/article/view/1797</self-uri><abstract><p>С применением новых наносоединений, в частности, производных фуллерена С60, возрастает вероятность контакта с ними человека. Показано, что водорастворимые производные фуллерена могут влиять на транскрипционную активность генов в эмбриональных фибробластах легких человека (ФЛЭЧ). Активация транскрипционного фактора NFkB (nuclear factor kappa-light-chain-enhancer of activated B cells) индуцирует процессы, направленные на выживание клеток, а также развитие провоспалительного ответа. Экспрессия генов, обеспечивающих защиту от стресса на клеточном уровне, запускается фактором транскрипции, NRF2 (nuclear factor [erythroid-derived 2]-like factor 2). Взаимодействие между NFkB и NRF2 в основном носит характер антагонизма. Поиск новых соединений, избирательно активирующих транскрипционный фактор NFkB и NRF2, остаётся актуальной задачей современной медицины.</p></abstract><trans-abstract xml:lang="en"><p>With the use of new nanocompounds, in particular, derivatives of fullerene C60, the likelihood of human contact with them increases. It has been shown that water-soluble derivatives of fullerene can affect the transcriptional activity of genes in human embryonic fibroblasts of the lungs (PLEC). Activation of the transcription factor NFkB (nuclear factor kappa-light-chain-enhancer of activated B cells) induces processes aimed at cell survival, as well as the development of a pro-inflammatory response. The expression of genes that provide protection against stress at the cellular level is triggered by a transcription factor, NRF2 (nuclear factor [erythroid-derived 2] -like factor 2). The interaction between NFkB and NRF2 is mainly antagonistic. The search for new compounds that selectively activate the transcription factor NFkB and NRF2 remains an urgent task of modern medicine.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>наносоединения</kwd><kwd>фуллерены</kwd><kwd>транскрипционные факторы</kwd></kwd-group><kwd-group xml:lang="en"><kwd>nanoconnections</kwd><kwd>fullerenes</kwd><kwd>transcription factors</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Sergeeva V., Kraevaya O., Ershova E., Kameneva L., Malinovskaya E., Dolgikh O., Konkova M., Voronov I., Zhilenkov A., Veiko N., Troshin P., Kutsev S., Kostyuk S. Antioxidant Properties of Fullerene Derivatives Depend on Their Chemical Structure: A Study of Two Fullerene Derivatives on HELFs. Oxid Med Cell Longev. 2019;2019:4398695.</mixed-citation><mixed-citation xml:lang="en">Sergeeva V., Kraevaya O., Ershova E., Kameneva L., Malinovskaya E., Dolgikh O., Konkova M., Voronov I., Zhilenkov A., Veiko N., Troshin P., Kutsev S., Kostyuk S. Antioxidant Properties of Fullerene Derivatives Depend on Their Chemical Structure: A Study of Two Fullerene Derivatives on HELFs. Oxid Med Cell Longev. 2019;2019:4398695.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Ershova E.S., Sergeeva V.A., Tabakov V.J., Kameneva L.A., Porokhovnik L.N., Voronov II, Khakina E.A., Troshin P.A., Kutsev S.I., Veiko N.N., Kostyuk S.V. Functionalized Fullerene Increases NF-κB Activity and Blocks Genotoxic Effect of Oxidative Stress in Serum Starving Human Embryo Lung Diploid Fibroblasts. Oxid Med Cell Longev. 2016;2016:9895245.</mixed-citation><mixed-citation xml:lang="en">Ershova E.S., Sergeeva V.A., Tabakov V.J., Kameneva L.A., Porokhovnik L.N., Voronov II, Khakina E.A., Troshin P.A., Kutsev S.I., Veiko N.N., Kostyuk S.V. Functionalized Fullerene Increases NF-κB Activity and Blocks Genotoxic Effect of Oxidative Stress in Serum Starving Human Embryo Lung Diploid Fibroblasts. Oxid Med Cell Longev. 2016;2016:9895245.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Kraevaya O.A., Peregudov A.S., Troyanov S.I., Godovikov I., Fedorova N.E., Klimova R.R., Sergeeva V.A., Kameneva L.V., Ershova E.S., Martynenko V.M., Claes S., Kushch A.A., Kostyuk S.V., Schols D., Shestakov A.F., Troshin P.A. Diversion of the Arbuzov reaction: alkylation of C-Cl instead of phosphonic ester formation on the fullerene cage. Org Biomol Chem. 2019; 17(30):7155-7160.</mixed-citation><mixed-citation xml:lang="en">Kraevaya O.A., Peregudov A.S., Troyanov S.I., Godovikov I., Fedorova N.E., Klimova R.R., Sergeeva V.A., Kameneva L.V., Ershova E.S., Martynenko V.M., Claes S., Kushch A.A., Kostyuk S.V., Schols D., Shestakov A.F., Troshin P.A. Diversion of the Arbuzov reaction: alkylation of C-Cl instead of phosphonic ester formation on the fullerene cage. Org Biomol Chem. 2019; 17(30):7155-7160.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
